FluidAI Medical, a Canadian medical technology company that develops Artificial Intelligence solutions integrating novel sensors, medical devices and software, received FDA 510(k) clearance for Origin™, a real-time monitoring device intended for use with patients recovering from surgery post-operatively.
KITCHENER, ON, Sept. 26, 2025 /PRNewswire/ – FluidAI announced that the U.S. Food and Drug Administration has granted 510(k) clearance for Origin™, an inline sensing system that provides real-time, bedside monitoring of surgical effluent for patients in a post-operative setting. Origin™ can either work as a standalone device and is planned to be integrated with FluidAI’s Stream Care™ – an AI-assisted Surgical Expert Suite (1). The device has been designed to seamlessly connect to standard surgical drains and continuously provide care teams with real-time pH data visualization at the bedside.